Ju W. Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Final Silence.

Final Silence.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 23, 2025

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial.

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial.

Journal: BMC cancer

Published: October 11, 2025

Comparative immunohistochemical expression of TROP2 in brain metastatic and primary tumors.

Comparative immunohistochemical expression of TROP2 in brain metastatic and primary tumors.

Journal: American journal of cancer research

Published: August 08, 2025

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience.

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience.

Journal: Translational lung cancer research

Published: July 10, 2025

Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).

Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 09, 2025

Eight-Year Trends in Megestrol Acetate Prescription Among Korean Patients with Biliary-Pancreatic Cancer and Their Impact.

Eight-Year Trends in Megestrol Acetate Prescription Among Korean Patients with Biliary-Pancreatic Cancer and Their Impact.

Journal: Nutrition and cancer

Published: May 26, 2025

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).

Journal: Breast (Edinburgh, Scotland)

Published: January 06, 2025

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial.

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial.

Journal: Cancer communications (London, England)

Published: December 17, 2024

Opposing regulation of the K63-linked polyubiquitination of RIPK3 by SMURF1 and USP5 in necroptosis.

Opposing regulation of the K63-linked polyubiquitination of RIPK3 by SMURF1 and USP5 in necroptosis.

Journal: Nature communications

Published: October 18, 2024

Machine Learning-Based Prognostic Gene Signature for Early Triple-Negative Breast Cancer.

Machine Learning-Based Prognostic Gene Signature for Early Triple-Negative Breast Cancer.

Journal: Cancer research and treatment

Published: September 26, 2024

Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial.

Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial.

Journal: JAMA oncology

Published: August 15, 2024

The effect of aroma lymphatic tressage on taxane-induced lower-extremity edema in breast cancer patients.

The effect of aroma lymphatic tressage on taxane-induced lower-extremity edema in breast cancer patients.

Journal: Japanese journal of clinical oncology

Published: May 17, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026